FFA Metabolism in Different Types of Human Obesity

Withdrawn

• Conditions: Obesity

• Registration Number: NCT00068900
• Lead Sponsor: Mayo Clinic

Brief Summary

We will give intravenous fat molecules to help us understand how the fat that is released from peoples fat cells is used. This will be done when people are eating, not eating and walking.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2003-09-10
• Study First Submitted QC: 2003-09-11
• Study First Posted: 2003-09-12
• Study Start: 2003-11
• Primary Completion: 2004-01
• Study Completion: 2004-02
• Status Verified: 2015-04
• Last Update Submitted: 2015-04-29
• Last Update Posted: 2015-04-30

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

BMI 28-36 -upper body obesity and lower body obesity non-obese BMI 19-24. Females premenopausal. Must be a non-smoker.

Exclusion Criteria

BP> 160/95 on HTN meds, known systemic illness. Medications that affect fat metabolism. We do no cover travel expenses. Known heart and vascular disease.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Rochester, Minnesota, United States